MN
Manav Nandwani
About Manav Nandwani
Data last updated:
Manav Nandwani is a Director at Trilok Pharma Private Limited (since 2019), Additional Director at Rabs Buildcon Private Limited (since 2015) and Director at Preventra Nutrition Private Limited (since 2025), and holds 2 more current directorships. The companies operate in Pharma, Real Estate and Construction and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹62.92 Cr; the largest is Trilok Pharma Private Limited at ₹59.67 Cr (FY 2025). Earlier, Manav Nandwani was a Director at Rajesh Specialities Private Limited (2020–2024) and Director at Zorg Life Sciences (India) Private Limited (2014–2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Trilok Pharma Private Limited U51100MP2019PTC049994 | Director | 05 Nov 2019 | 2019 | ₹59.67 Cr (FY 2025) | Active |
| Rabs Buildcon Private Limited U45200MP2012PTC027745 | Additional Director | 29 Jan 2015 | 2012 | ₹3.25 Cr (FY 2025) | Active |
| Preventra Nutrition Private Limited U10799KA2025PTC208553 | Director | 16 Sep 2025 | 2025 | Active | |
| Marks Realty Developers Private Limited U68200MP2025PTC077296 | Director | 13 Jun 2025 | 2025 | Active | |
| Swaarnam Infraspace Private Limited U43299MP2025PTC076483 | Director | 30 Apr 2025 | 2025 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Rajesh Specialities Private Limited U33208MP2020PTC052185 | Director | 06 Aug 2020 | 2020 | ₹66.16 Cr (FY 2025) | Active |
_PRIVATE_LIMITED.webp){kind=small} Zorg Life Sciences (India) Private Limited U24211MP2014PTC033401 | Director | 10 Nov 2014 | 2014 | ₹15.93 Cr (FY 2024) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Manav Nandwani
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anil Kumar Nandwani | 00602268 | Trilok Pharma Private Limited , Rabs Buildcon Private Limited | Director |
| Aman Sohaney | 06561967 | Rabs Buildcon Private Limited | Additional Director |
| Arpit Agrawal | 07091294 | Rabs Buildcon Private Limited | Additional Director |
| Brajesh Sohaney | 01369096 | Rabs Buildcon Private Limited | Director |
| Rajesh Nandwani | 00932491 | Rabs Buildcon Private Limited , Marks Realty Developers Private Limited and 1 more | Director |
| Sarita Agrawal | 07123080 | Rabs Buildcon Private Limited | Additional Director |
| Sekhar Saraf | 05333866 | Rabs Buildcon Private Limited | Additional Director |
| Shyam Sohaney | 01550001 | Rabs Buildcon Private Limited | Director |
| Pratishtha Singh | 10576609 | Preventra Nutrition Private Limited | Director |
| Pushpa Yadav | 06932131 | Swaarnam Infraspace Private Limited | Director |
| Satyendra Kumar Yadav | 05210649 | Swaarnam Infraspace Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Manav Nandwani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Manav Nandwani
Manav Nandwani currently holds 5 directorships: Trilok Pharma Private Limited (Director, since 05 Nov 2019, revenue ₹59.67 Cr (FY 2025)); Rabs Buildcon Private Limited (Additional Director, since 29 Jan 2015, revenue ₹3.25 Cr (FY 2025)); Preventra Nutrition Private Limited (Director, since 16 Sep 2025); Marks Realty Developers Private Limited (Director, since 13 Jun 2025); Swaarnam Infraspace Private Limited (Director, since 30 Apr 2025).
Manav Nandwani was first appointed on 10 Nov 2014 as Director at Zorg Life Sciences (India) Private Limited. The most recent appointment on record is 16 Sep 2025 at Preventra Nutrition Private Limited.
The 2 current companies of Manav Nandwani that report revenue have a combined latest revenue of ₹62.92 Cr: Trilok Pharma Private Limited ₹59.67 Cr (FY 2025); Rabs Buildcon Private Limited ₹3.25 Cr (FY 2025).
Manav Nandwani held 2 earlier board appointments: Rajesh Specialities Private Limited (Director, 06 Aug 2020 to 21 Sep 2024); Zorg Life Sciences (India) Private Limited (Director, 10 Nov 2014 to 21 Sep 2024).
The current boards of Manav Nandwani's companies include Anil Kumar Nandwani (Trilok Pharma Private Limited), Aman Sohaney (Rabs Buildcon Private Limited), Arpit Agrawal (Rabs Buildcon Private Limited), Brajesh Sohaney (Rabs Buildcon Private Limited), Rajesh Nandwani (Rabs Buildcon Private Limited), Sarita Agrawal (Rabs Buildcon Private Limited), among others.